Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frishman

Showing results (351-360 of 1,860) with videos related to

Pageof 186
Sort By:
The American Journal of Cardiology|October 1, 1982
Verapamil therapy for stable and unstable angina pectoris: calcium channel antagonists in perspectiveM Packer, W H Frishman
Cardiology in Review|July 2, 2025
Pompe Disease: Current State and Future TreatmentsMargot Richards, William H Frishman
Cardiology in Review|September 18, 2025
Beyond Glycemic Control: Glucagon-Like Peptide-1 Receptor Agonists as Potential Modifiers of Aortic DiseaseKanwardeep Singh, William H Frishman
Cardiology in Review|September 15, 2025
Management of Atrial Septal Defect in the Adult PopulationRhea Munjal, William H Frishman
Cardiology in Review|December 6, 2013
Air pollution exposure as a risk factor for cardiovascular disease morbidity and mortalityAnna Koulova, William H Frishman
Cardiology in Review|May 28, 2013
Newer therapeutic strategies to alter high-density lipoprotein level and functionNicholas Bosch, William H Frishman
The Medical Clinics of North America|March 1, 1989
Calcium antagonists and heart failureS Charlap, W H Frishman
The American Journal of the Medical Sciences|May 28, 2021
The Case For Cadmium and Lead Heavy Metal ScreeningDaniel Glicklich, William H Frishman
Cardiology in Review|June 16, 2021
A Review of the Role of Type 2 Diabetes Mellitus and Sodium-Glucose Cotransporter-1 Inhibitors in Heart Failure With Preserved Ejection FractionGladys I Palaguachi, William Frishman
Cardiology in Review|May 16, 2022
Mild-to-Moderate COVID-19 Infection and Myocarditis: A ReviewEric Bailey, William H Frishman
Pageof 186

Showing results (351-360 of 1,860) with videos related to

Sort By:
Pageof 186
The American Journal of Cardiology|October 1, 1982
Verapamil therapy for stable and unstable angina pectoris: calcium channel antagonists in perspectiveM Packer, W H Frishman
Cardiology in Review|July 2, 2025
Pompe Disease: Current State and Future TreatmentsMargot Richards, William H Frishman
Cardiology in Review|September 18, 2025
Beyond Glycemic Control: Glucagon-Like Peptide-1 Receptor Agonists as Potential Modifiers of Aortic DiseaseKanwardeep Singh, William H Frishman
Cardiology in Review|September 15, 2025
Management of Atrial Septal Defect in the Adult PopulationRhea Munjal, William H Frishman
Cardiology in Review|December 6, 2013
Air pollution exposure as a risk factor for cardiovascular disease morbidity and mortalityAnna Koulova, William H Frishman
Cardiology in Review|May 28, 2013
Newer therapeutic strategies to alter high-density lipoprotein level and functionNicholas Bosch, William H Frishman
The Medical Clinics of North America|March 1, 1989
Calcium antagonists and heart failureS Charlap, W H Frishman
The American Journal of the Medical Sciences|May 28, 2021
The Case For Cadmium and Lead Heavy Metal ScreeningDaniel Glicklich, William H Frishman
Cardiology in Review|June 16, 2021
A Review of the Role of Type 2 Diabetes Mellitus and Sodium-Glucose Cotransporter-1 Inhibitors in Heart Failure With Preserved Ejection FractionGladys I Palaguachi, William Frishman
Cardiology in Review|May 16, 2022
Mild-to-Moderate COVID-19 Infection and Myocarditis: A ReviewEric Bailey, William H Frishman
Pageof 186